Abstract:BACKGROUND:Compared with viral vectors, nonviral vectors are less immunogenic, more stable, safer and easier to replication for application in cancer gene therapy. However, nonviral gene delivery system has not been extensively used because of the low transfection efficiency and the short transgene expression, especially in vivo. It is desirable to develop a nonviral gene delivery system that can support stable genomic integration and persistent gene expression in vivo. Here, we used a composite nonviral gene delivery system consisting of the piggyBac (PB) transposon and polyethylenimine (PEI) for long-term transgene expression in mouse ovarian tumors.METHODS:A recombinant plasmid PB [Act-RFP, HSV-tk] encoding both the herpes simplex thymidine kinase (HSV-tk) and the monomeric red fluorescent protein (mRFP1) under PB transposon elements was constructed. This plasmid and the PBase plasmid were injected into ovarian cancer tumor xenografts in mice by in vivo PEI system. The antitumor effects of HSV-tk/ganciclovir (GCV) system were observed after intraperitoneal injection of GCV. Histological analysis and TUNEL assay were performed on the cryostat sections of the tumor tissue.RESULTS:Plasmid construction was confirmed by PCR analysis combined with restrictive enzyme digestion. mRFP1 expression could be visualized three weeks after the last transfection of pPB/TK under fluorescence microscopy. After GCV admission, the tumor volume of PB/TK group was significantly reduced and the tumor inhibitory rate was 81.96% contrasted against the 43.07% in the TK group. Histological analysis showed that there were extensive necrosis and lymphocytes infiltration in the tumor tissue of the PB/TK group but limited in the tissue of control group. TUNEL assays suggested that the transfected cells were undergoing apoptosis after GCV admission in vivo.CONCLUSION:Our results show that the nonviral gene delivery system coupling PB transposon with PEI can be used as an efficient tool for gene therapy in ovarian cancer.

Regression of Tumors by IFN-α Electroporation Gene Therapy and Analysis of the Responsible Genes by Cdna Array

Intramuscular Electroporation Delivery of IFN-α Gene Therapy for Inhibition of Tumor Growth Located at a Distant Site

Effects of gamma-interferon gene-modified hepatocytes on murine implanted liver carcinoma

Antitumor Efficacy of Combination of Interferon-Gamma-inducible Protein 10 Gene with Gemcitabine, a Study in Murine Model

Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus-Thymidine Kinase/ganciclovir Direct Intratumoral Gene Therapy of Hepatocellular Carcinoma

Epithelial Ovarian Cancer: Feasibility of Image-Guided Intratumoral Radiofrequency Hyperthermia-Enhanced Direct Gene Therapy

Therapeutic Effect of Pegr-Il18-b7.2 Gene Radiotherapy in B16 Melanoma-Bearing Mice.

Therapeutic effect of gene-therapy in combination with local X-irradiation in a mouse malignant melanoma model.

Tumor radiosensitization by gene therapy against endoglin

Modulation of Gene Expression in MHCC97 Cells by Interferon Alpha

Enhancement of Tumor Klling Using a Combination of E. Coli Cytosine Deaminase Gene and INF-#gamma# Gene Therapy

Delivery of Interferon Β-Encoding Plasmid Via Lipid Nanoparticle Restores Interferon Β Expression to Enhance Antitumor Immunity in Colon Cancer.

Gene Therapy with Tumor-Specific Promoter Mediated Suicide Gene Plus IL-12 Gene Enhanced Tumor Inhibition and Prolonged Host Survival in a Murine Model of Lewis Lung Carcinoma

Target gene transfer mediated by electroporation for cancer therapy in vivo

Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-β expression driven by hTERT promoter

Tumor-directed Gene Therapy in Mice Using a Composite Nonviral Gene Delivery System Consisting of the Piggybac Transposon and Polyethylenimine

Anti-tumor Effects of Egr-IFNγ Gene Therapy Combined with 125I-Udr Radionuclide Therapy

Enhanced Antitumor Effect of EGF R–targeted P21waf-1 and GM-CSF Gene Transfer in the Established Murine Hepatoma by Peritumoral Injection

Pan-cancer analysis of IFN-γ with possible immunotherapeutic significance: a verification of single-cell sequencing and bulk omics research

Targeted in Vivo Expression of IFN-gamma-inducible Protein 10 Induces Specific Antitumor Activity.

Adenovirus-mediated combined suicide gene and interleukin-2 gene therapy for the treatment of established tumor and induction of antitumor immunity